1. ALLA AKTIER
  2. NYHETER
  3. XBRANE BIOPHARMA

Xbrane Biopharma

Nyheter Xbrane Biopharma Nyheter alla bolag

Invitation to presentation of Xbrane Biopharma’s interim report January – March 2022 on May 5, 2022.

Xbrane Biopharma AB invites to a teleconference for investors, analysts and media on Thursday, May 5, 2022, at 11.00 a.m. CET. Xbrane will publish the company’s interim report January – March 2022, on Thursday, May 5, 2022, at 8.00 a.m. CET.

Martin Åmark, CEO, and Anette Lindqvist, CFO/IR, will present the interim report January – March 2022, followed by a Q&A session. The presentation will be in English. To attend, please follow the link or dial-in at one of the numbers below:

Web link:
Xbrane interim report January - March 2022 presentation

Confirmation Code: 304 98 28
Standard international: +44 (0) 2071 928 338
UK (Local): +44 (0) 844 481 97 52
UK (Tollfree): +44 (0) 800 279 66 19
Sweden (Local): +46 (0) 856 618 467
Sweden (TollFree): +46 (0) 200 125 160
US (Local): +1 646 741 31 67
US (TollFree): +1 877 870 91 35

Contacts

Martin Åmark, CEO
M: +46 76 309 37 77
E: martin.amark@xbrane.com

Anette Lindqvist, CFO/IR
M: +46 76 325 60 90
E: anette.lindqvist@xbrane.com

About Us

Xbrane Biopharma AB develops biological drugs based on a patented platform technology that provides significantly lower production costs compared to competing systems. Xbrane has a portfolio of biosimilar candidates targeting SEK 332 billion in annual sales of the respective reference products, with the leading one under registration in Europe. Xbrane’s head office is in Solna, just outside Stockholm. Xbrane is listed on Nasdaq Stockholm under the ticker XBRANE. For more information, visit www.xbrane.com  

Attachments

Invitation to presentation of Xbrane Biopharma’s interim report January – March 2022 on May 5, 2022.

Datum 2022-05-02, kl 14:00
Källa MFN
Bifogade filer
Invitation to presentation of Xbrane Biopharma’s interim report January – March 2022 on May 5, 2022.
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 125 000 sidvisningar och 17 000 unika besökare per månad. Vår discord har 7800 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!